Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105274 · ClinicalTrials.gov registry record
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
NCT00105274: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00105274 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105274 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
Study Summary
Velocardiofacial syndrome, also known as 22q11.2 syndrome or DiGeorge syndrome, has been associated with many features such as a cleft palate, heart defects, and learning, speech and feeding problems. It is caused by the absence of a number of genes on chromosome 22, but the mechanism by which this inborn abnormality causes the clinical problems is not known. In this study by the National Institute of Mental Health and the Office of Rare Diseases, we are recruiting participants with 22q11.2 syndrome to come for a three-day stay to our main campus in Bethesda, MD, to participate in a study in which we will investigate the genetic makeup of their cells together with several studies of brain function with advanced research imaging. The goal of this study is to understand how the genes missing in 22q11.2 syndrome are related to the increased occurrence of psychiatric problems, such as psychosis, in this syndrome. Participants must be 18-50 years of age, have some high school education and not currently be taking antipsychotic medication. Travel costs to Bethesda for participants and an accompanying person will be paid, and participants are reimbursed for their time in participating in the study. A blood draw is required. All research procedures have been designated as "minimal risk" procedures. ...
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-03-07 |
| Est. Completion | 2010-02-02 |
What the finished NCT00105274 record still lists
NCT00105274 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00105274 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00105274 about?
NCT00105274 is a clinical study titled "Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study". Velocardiofacial syndrome, also known as 22q11.2 syndrome or DiGeorge syndrome, has been associated with many features such as a cleft palate, heart defects, and learning, speech and feeding problems. It is caused by the absence of a number of genes on chromosome 22, but the mechanism by which this ...
What is the current status of trial NCT00105274?
This trial is currently completed. The study started on 2005-03-07. Estimated completion is 2010-02-02.
Who is sponsoring clinical trial NCT00105274?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI